{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Central Nervous System Hemangioblastomas: Part I -- Incidence - Vol. 37, No. 25

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Analyze the incidence of central nervous system hemangioblastomas associated with von Hippel-Lindau (VHL) disease.
  2. Distinguish the gross pathologic and histologic characteristics of central nervous system hemangioblastomas associated with VHL disease.
  3. Evaluate the genetic and molecular basis of VHL disease.

Disclosures

All faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any), have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations related to this CME activity.

Price: $49.00

Credits:

  • ACCME 1.5 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: CNE1215B
Published: December 15, 2015
Expires: 1/1/2026
Sources: Contemporary Neurosurgery
Required Passing Score: 7/10 (70%)
Authors: James Pan, BS, Eric Sussman, MD, Armine Tayag, MSN, Patricia Thompson, MSN, and Steven D. Chang, MD
Categories: Tumor
Specialties: Neurological Surgery
Topics: Central Nervous System Hemangioblastoma , Von Hippel-Lindau Disease